HomeITOS • NASDAQ
add
iTeos Therapeutics Inc
Previous close
$10.02
Day range
$9.65 - $10.22
Year range
$8.20 - $18.75
Market cap
357.91M USD
Avg Volume
778.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
NDAQ
1.73%
0.94%
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 35.00M | — |
Operating expense | 48.27M | 14.30% |
Net income | -7.13M | 79.22% |
Net profit margin | -20.37 | — |
Earnings per share | -0.18 | 81.25% |
EBITDA | -12.96M | 69.14% |
Effective tax rate | -46.46% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 571.26M | -4.67% |
Total assets | 751.84M | 6.83% |
Total liabilities | 87.97M | 9.66% |
Total equity | 663.87M | — |
Shares outstanding | 36.52M | — |
Price to book | 0.55 | — |
Return on assets | -4.80% | — |
Return on capital | -5.46% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -7.13M | 79.22% |
Cash from operations | -33.93M | -14.83% |
Cash from investing | 16.32M | -18.81% |
Cash from financing | 122.38M | 56,035.78% |
Net change in cash | 104.48M | 1,246.52% |
Free cash flow | -25.38M | -37.49% |
About
Founded
2011
Headquarters
Website
Employees
157